Study designs of evaluations included in the review
Randomised controlled trials (RCTs) were eligible for inclusion.
Specific interventions included in the review
Studies that compared occlusal splint or occlusal adjustment with placebo, no treatment or another intervention were eligible for inclusion. Studies that compared different types of splint were excluded. Studies of combinations of splint or occlusive adjustment with other treatments were subsequently excluded. The included studies used stabilisation (flat plane) splints, soft splints and anterior repositioning splint (for TM joint dislocation). The control treatments varied widely and included one or more of the following: biofeedback, ultrasound, relaxation training, movement feedback, acupuncture, transcutaneous electrical nerve stimulation, muscle exercise, palatal splint, different stomatognathic treatments, mock occlusal adjustment and waiting-list. Some studies permitted no other treatments for pain, while one study gave pain medication to all patients.
Participants included in the review
Studies of people seeking treatment for symptoms of TMD were eligible for inclusion. The included studies were of people referred for treatment and people recruited through newspaper advertisements. The participants in the included studies had mandibular dysfunction, myofacial pain dysfunction syndrome, pain and dysfunction of the masticatory system plus reciprocal clicking or disk displacement, masticatory muscle myalgia, facial muscular pain, craniomandibular disorder, TM joint disk displacement without reduction, and TMD including TMD of arthrogenous origin.
Outcomes assessed in the review
The inclusion criteria were not explicitly defined in terms of the outcomes. The review assessed the difference between treatments in pain intensity, overall success rating, or any other outcomes measures used in the studies. In the included studies:
pain was assessed using pain diary, pain visual analogue scale, pain severity scale, pain unpleasantness, verbal rating, pain frequency and a symptom severity index;
overall success was assessed on the basis of success rating, improvement of subjective symptoms, subjective improvement, positive responders and change in severity; and
other measures were assessed using subjective symptoms, reciprocal clicking, palpatory tenderness or palpation score, joint sounds, clicking, TMD questionnaire, Helkimo clinical index, Helkimo anamnestic index, activity of daily living, clinical variables, muscle pain palpation index, depression scale, quality of life, frequency and severity of complaints, symptom questionnaire, pressure algometer score, maximum pain free opening, subjective and clinical dysfunction score, prevalence of symptoms and clinical signs.
The duration of follow-up ranged from 10 days to 12 months. The review focused on the latest outcome assessment.
How were decisions on the relevance of primary studies made?
The authors independently read each identified paper and reached consensus on the studies selected for inclusion.